Navigation Links
Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
Date:1/18/2008

SOMERSET, N.J., Jan. 18 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that it has entered into a purchase and supply agreement with Scientific Protein Laboratories LLC (SPL) for the commercial production of ONCONASE(R) (ranpirnase). ONCONASE, the company's lead drug candidate, is currently being evaluated as a treatment for unresectable malignant mesothelioma (UMM) in a confirmatory Phase IIIb clinical trial.

"SPL has been involved in the production of ONCONASE from the very first batches," said Kuslima Shogen, chief executive officer of Alfacell. "We have been pleased with the superb performance of the extremely well qualified team at SPL for many years and are confident that the commercial production of ONCONASE is in the right hands. This agreement is another step forward for Alfacell as we plan for the commercialization of ONCONASE."

"We have been very enthusiastic about the Alfacell project from the very beginning," said David Strunce, president and chief executive officer of SPL. "We are impressed by the way that Alfacell has successfully guided their novel product through the development phases, and we are pleased to have the opportunity to continue the collaboration with the Alfacell team into the commercial stage."

About Scientific Protein Labs LLC

For over three decades, Scientific Protein Laboratories (SPL) has been a leading global supplier of high quality active pharmaceutical ingredients (APIs) from natural sources. The company specializes in cGMP biopharmaceutical manufacturing and is among the largest commercial suppliers of Heparin Sodium USP, Pancreatin USP and Pancrelipase USP in serving the pharmaceutical, veterinary and food industries globally. Beyond supply
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
2. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
3. Alfacell to Present at BIO InvestorForum 2007
4. Peptimmune Announces First Close of Series D Private Financing
5. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
6. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
7. Vasogen Announces 2007 Year-End Results
8. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
9. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
10. Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
11. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 ..., policy makers, and funders today convened to exp...unding strategies at the inaugural Partnering for...ton-based center of the Milken Institute, convened... collaborations needed to turn a scientific discov...
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCa...PHM ) today reported completion of patient enrollm...Cotara® in patients with relapsed glioblastom...ncer. Cotara is a targeted monoclonal antibody li...ial new treatment for GBM. Cotara specifically ta...
(Date:12/2/2009)... , LIBREVILLE, Gabon, December 2 /PRNewswir...ica: Everyone,s Problem and Heritage" , C...ity, 2-3 June 2010 the,Gabonese Republic is hostin...) on the issue of safeguarding biological resource...vernment and state leaders, ministers,scientific ...
(Date:12/2/2009)... , CAMBRIDGE, Mass., Dec. 2 /PRNewswire/ -...e leaders in technology development and product in..., announced the December 11th deadline for technol...w in its 14th year, TechConnect World, in associat... (NSTI), and the Clean Technology and Sustainable ...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
...n of American Medical Colleges (AAMC) recently app... Education" not only addresses funding of med...lp medical schools and teaching hospitals better m...ant element of these guidelines is the clear separ...ollaboration in scientific publications. Unfortuna...
...sdaq: BHRT ) a biotechnology company that is focu...ved) cell therapies and devices for the,treatment ... that its Board,of Directors appointed Howard J. L...oard and Chief Technology Officer, to serve as Chi... This follows the resignation of,William M. Pinon ...
...oldings, Inc. (Nasdaq: ADLS ), a biopharmaceutica...d commercialization of novel drugs in the,therapeu...eases, today,announced that it was added to the Ru...nt Group reconstituted its comprehensive set of U....Logo: http://www.newscom.com/cgi-bin/prnh/2008021...
Other Biology Technology:ISMPP Applauds AAMC Clarification on Ghostwriting Versus Transparent Writing Collaboration in Scientific Publications 2ISMPP Applauds AAMC Clarification on Ghostwriting Versus Transparent Writing Collaboration in Scientific Publications 3Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer 2Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer 3Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3
(Date:12/1/2009)...rman . , Brown adipose tissue is different fro...ia, miniature power stations which among other thi...enerate a voltage similar to that of a battery, wh...owever, the mitochondria of brown fat cells have a...ime. The energy released when the fat is broken do...
(Date:12/1/2009)...009 Inserm Grand Prix., Every year since 2000, I...e to outstanding,work performed in its laboratori...ntends to,demonstrate the diversity and wealth of...l and,health research, and the creativity and pas... this research each day. The Inserm 2009 prize-giv...
(Date:12/1/2009)...ewswire/ -- iQor, a global provider of business pr...the 2009 InfoWorld 100 Awards Top 100 IT project...21. This was the first submission for iQor. ,, ...gious list of companies," said Vikas Kapoor, presi...rming the way we do business, allowing us to work ...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Expert Explains Why Propofol Was the Wrong and Possibly Fatal Drug for Michael Jackson 50839 1Expert Explains Why Propofol Was the Wrong and Possibly Fatal Drug for Michael Jackson 50839 2Press Ganey Announces Opening of Boston Office 50837 1Press Ganey Announces Opening of Boston Office 50837 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 1Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 2Economy Forces Most Wired Hospitals to Look Closely at IT Spending 50835 3
...efforts towards developing a,vaccine against HIV i...e publication today of the Global HIV/AIDS Vaccine... online in the freely available,open-access globa...S Vaccine Enterprise is an international alliance ...ng or supporting HIV,vaccine research. In June 200...
..., researchers present a “cautionary tale?about wha... proteomics to devise a diagnostic test for cancer...e National Cancer Institute, researchers from The ...etail why an experimental test intended to identif...d is unlikely to lead to a reliable clinical test ...
..., researchers present a “cautionary tale?about wha... proteomics to devise a diagnostic test for cancer...e National Cancer Institute, researchers from The ...etail why an experimental test intended to identif...d is unlikely to lead to a reliable clinical test ...
Other Biology News:A much-needed shot in the arm for HIV vaccine development 2A much-needed shot in the arm for HIV vaccine development 3Signaling protein builds bigger, better bones in mice 2Signaling protein builds bigger, better bones in mice 3Another Look Finds Promising Proteomics Test is Not Biologically Plausible 2Another Look Finds Promising Proteomics Test is Not Biologically Plausible 3
...inally formulated to support the growth of cells d...ea eucalypti. The medium is a modification of Wyat...ph. The cell lines established by Grace using this... The basal medium, when properly supplemented, has...
Vsp I from Promega
CERTOMAT U from Sartorius AG
...id, convenient, and efficient Denatured protein co...lute process utilizes a spin column to make handli...roteins which were electro-eluted in their Denatur... offering high binding capacity fo all pH values. ...
Biology Products: